Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial

Journal:

The Lancet Oncology

Published:

2026-01-20

DOI:

10.1016/s1470-2045(25)00679-5

Affiliations:

17

Authors:

22

Go to article

Institutions	Authors	Share
University Medical Center, MUI, Austria	4.058824	0.18
Homi Bhabha National Institute (HBNI), India	2.058824	0.09
Kansai Medical University Hospital, Japan	2.058824	0.09
King Hussein Cancer Center, Jordan	2.058824	0.09
CHRU de Besançon, France	1.058824	0.05
Clinical Hospital Centre Rijeka (KBCRI), UNIRI, Croatia	1.058824	0.05
University Hospital in Halle (Saale) (UKH), MLU, Germany	1.058824	0.05
Bezirkskrankenhaus Kufstein, Austria	1.058824	0.05
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India	1.058824	0.05
Russian Oncological Scientific Center named after N.N.Blokhin, RAMS, Russia	1.058824	0.05
Copenhagen University Hospital (CUH), Denmark	1.058824	0.05
Tata Memorial Hospital (TMH), TMC, India	1.058824	0.05
Martin Luther University Halle-Wittenberg (MLU), Germany	1.058824	0.05
University of Rijeka (UNIRI), Croatia	0.558824	0.03
Hospital Brotzu, Italy	0.558824	0.03
University of Maribor, Slovenia	0.558824	0.03
University of Cagliari (UNICA), Italy	0.558824	0.03

Interested in Oncology and Carcinogenesis?